Loading clinical trials...
Loading clinical trials...
This study examines how head and neck cancer treatment affects quality of sleep over time and factors that contribute to sleep quality. Sleep plays a critical role in healing and quality of life, and recent studies investigating sleep disorders in head and neck cancer patients reveal sleep quality is a major determinant of post-treatment outcomes. Information from this study may help researchers better understand how treatment impacts sleep quality so that they can make changes that may help improve patient sleep quality.
PRIMARY OBJECTIVES: I. To describe the five (5) components of sleep quality in head and neck patients under different stages of post-op treatment and different environment. II. To evaluate the effect of surgery, treatment and environment on the five (5) components of sleep quality in head and neck cancer patients. SECONDARY OBJECTIVES: I. To evaluate the association between the five (5) components of sleep quality and comorbid obstructive sleep apnea (STOP-BANG and Epworth Sleeping Scale) and depression (Patient Health Questionnaire-2 \[PHQ-2\]), under different stages of post-op treatment and different environment. II. To evaluate the association between Fitbit actigraphy data (i.e. the 5th component of sleep quality) and the first 4 components of sleep quality for inpatients. III. To compare the inpatient versus the outpatient responses on sleep hygiene at different time points of measurement. EXPLORATORY OBJECTIVE: I. To assess whether survey results warrant additional counseling or patient education. OUTLINE: COHORT 1-TP1: Patients complete surveys over 20 minutes on post-op day 3 and on day of discharge (or within 1 week). COHORT 1-TP2: Patients complete surveys over 15 minutes at all regularly scheduled follow-up appointments (approximately 1 month, 3 months, 6 months, 12 months). COHORT 2: Patients complete surveys over 15 minutes once.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Start Date
January 1, 2022
Primary Completion Date
October 24, 2024
Completion Date
December 1, 2025
Last Updated
September 29, 2025
Survey Administration
OTHER
Lead Sponsor
Thomas Jefferson University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions